Research from early clinical trials of pediatric glioma patients shows that altered immune cells can fight the deadly brainstem tumor.
The common antidepressant Prozac melts away glioblastoma tumors in laboratory mice, suggesting possible treatment for the deadly cancer.
A clinical trial studying convalescent plasma in COVID patients was determined ineffective by the National Institutes of Health and others.
Anxious to protect her children, Stanford immunology researcher enrolls her two young children Pfizer’s COVID-19 vaccine clinical trial for kids.
A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.
Doctors and researchers are prioritizing a digital-first approach as they adapt clinical trials to the COVID-19 pandemic.
Stanford Medicine researcher John Ioannidis calls for transparency and the sharing of data, a lesson learned through COVID-19.
Stanford Medicine researchers are investigating SARS-CoV-2 to address the COVID-19 pandemic and ultimately help restore normalcy to society.
Stanford infectious disease expert Yvonne Maldonado, MD, describes principles for developing safe and effective COVID-19 vaccines for everyone.
Technology that sends blood sugar-level updates to their smartphones improves outcomes for young people with type 1 diabetes, a Stanford trial shows.
Many early clinical studies of COVID-19 fail to meet quality standards, raising concerns that the data could be of little meaningful use, research finds.
A Stanford microbiologist describes the invigorating, yet sobering race to develop an effective vaccine against COVID-19.
The Innovative Medicines Accelerator builds on existing programs at Stanford — but fills in gaps to help researchers turn ideas into drugs.
Stanford Medicine will be the first to use a new technology that aims to heighten precision of radiation therapy in cancer patients.
In a clinical trial, a tiny prosthetic retinal device invented by a Stanford researcher has proved its potential ability to restore eyesight to the blind.
A study links ulcerative colitis to the depletion of important acids ordinarily produced by a set of gut microbes mysteriously missing in action.